BOSTON (Reuters) – William Ackman’s hedge fund is boasting double-digit gains at a time many portfolios have sunk along with the economy during the coronavirus pandemic, after the billionaire investor plowed cash into a number of companies he already owned and... More »
BOSTON (Reuters) – Billionaire investor William Ackman said a CNBC television interview he gave last week was not designed to profit from any trades, dismissing some media speculation he had purposely pushed markets lower to make money off his hedges. “Our hed... More »
BOSTON (Reuters) – Billionaire investor William Ackman, who has long worried about risks posed by the coronavirus, called on the Trump administration on Wednesday to seal off the country for 30 days and said stocks would “soar” if such restrictions were impose... More »
(Reuters) – William Ackman’s publicly traded hedge fund gained nearly 3% this year, though the billionaire investor warned of volatility ahead as world markets reel under the economic hit from the coronavirus epidemic. Pershing Square Holdings Ltd on Monday sa... More »
BOSTON (Reuters) – Two days after billionaire investor William Ackman told clients that he was making money across all his funds again, he said on Thursday that his publicly traded Pershing Square Holdings Ltd portfolio was barely in the black so far this year... More »
FILE PHOTO – William Ackman U.S. on November 10, 2015. REUTERS/Brendan McDermid/File Photo NEW YORK (Reuters) – Billionaire investor William Ackman said on Thursday that his hedge fund Pershing Square Capital Management made a new bet on sportswear company Nik... More »
Activist investor William Ackman, currently battling for board seats at Automatic Data Processing Inc (ADP.O), on Thursday said the human resource software company should buy rival Ceridian, in a move that could woo customers with a better product. More »
Billionaire investor William Ackman on Friday said his Pershing Square Capital Management hedge fund plans to nominate directors to, but not try to control, the 10-person board at payroll services company Automatic Data Processing Inc (ADP.O). More »
William ‘Bill’ Ackman, CEO and Portfolio Manager of Pershing Square Capital Management, speaks during the Sohn Investment Conference in New York City, U.S., May 8, 2017. REUTERS/Brendan McDermid Bayliss More »
William ‘Bill’ Ackman, CEO and Portfolio Manager of Pershing Square Capital Management, speaks during the Sohn Investment Conference in New York City, U.S., May 8, 2017. REUTERS/Brendan McDermid Bayliss More »
William Ackman speaks during the Sohn Investment Conference in New York May 4, 2015. REUTERS/Brendan McDermid Bayliss More »
FILE PHOTO – William Ackman (L), chief executive of Pershing Square Capital, speaks with David Weinreb, CEO of Howard Hughes Corp. on the floor of the New York Stock Exchangein New York, U.S. on November 10, 2015. REUTERS/Brendan McDermid/File Photo Bayliss More »
FILE PHOTO – William Ackman, chief executive of Pershing Square walks on the floor of the New York Stock Exchange, New York, U.S. on November 10, 2015. REUTERS/Brendan McDermid/File Photo Bayliss and Michael Flaherty More »
William Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks during the Sohn Investment Conference in New York May 4, 2015. REUTERS/Brendan McDermid Billionaire investor William Ackman on Thursday said he has had an “extremely const... More »
BOSTON A widening criminal probe casts new light on a bitter defeat hedge fund activist Bill Ackman suffered in his 2009 bid for board seats at U.S. retailer Target Corp. Target for years has paid proxy solicitor Georgeson LLC to track the votes of its top inv... More »
BOSTON Billionaire investor William Ackman’s Pershing Square Holdings, Ltd fund lost 7.1 percent last month, hurt largely by Valeant Pharmaceuticals’ (VRX.TO) roughly 60 percent tumble in March. March’s poor performance leaves Ackman’s fund with a 25.6 percent... More »
BOSTON Billionaire investor William Ackman, whose hedge fund is one of the biggest investors in drug company Valeant, has been asked to supply information to U.S. legislators probing price hikes in the pharmaceutical industry. Ackman told investors in his Pers... More »
NEW YORK Billionaire investor Bill Ackman on Tuesday called embattled drug company Valeant Pharmaceuticals a “very valuable asset” but forecast that if the company’s situation does not stabilize soon new management will be brought in or the company will be sol... More »
BOSTON Sitting on a double-digit loss that is the deepest in his firm’s history, billionaire investor Bill Ackman on Tuesday told investors that he made mistakes last year in not cutting two big positions but said he sees plenty of new investment opportunities... More »
BOSTON Billionaire hedge fund investor William Ackman, whose funds have suffered double-digit losses this year, on Tuesday told investors that 2015 could be his firm’s worst ever, but said clients are generally sticking with him. “If the year finishes with our... More »
BOSTON Hedge fund mogul William Ackman’s Pershing Square Holdings portfolio fell 13.1 percent this month, leaving the fund down 4.3 percent for the year, the firm said on Thursday. The performance numbers cover returns through Tuesday, Aug. 25. On Wednesday, A... More »
